Israel Englander Oyster Point Pharma, Inc. Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.95 - $11.68 $792,638 - $1.16 Million	99,703 Added 93.57%	206,254 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$4.41 - $8.38 $123,863 - $235,369	-28,087 Reduced 20.86%	106,551 $599,000
Q2 2022 Aug 15, 2022	BUY	$3.6 - $11.2 $484,696 - $1.51 Million	134,638 New	134,638 $583,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $1.03 Million - $2.11 Million	-119,783 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $829,983 - $1.55 Million	81,611 Added 213.8%	119,783 $2.19 Million
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $30,493 - $47,216	2,613 Added 7.35%	38,172 $452,000
Q2 2021 Aug 16, 2021	SELL	$16.25 - $21.51 $375,846 - $497,504	-23,129 Reduced 39.41%	35,559 $611,000
Q1 2021 May 17, 2021	SELL	$17.92 - $25.86 $852,633 - $1.23 Million	-47,580 Reduced 44.77%	58,688 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$18.13 - $25.18 $1.03 Million - $1.42 Million	-56,547 Reduced 34.73%	106,268 $2 Million
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $633,054 - $1.03 Million	35,505 Added 27.89%	162,815 $3.44 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $3.37 Million - $4.34 Million	120,898 Added 1885.5%	127,310 $3.68 Million
Q1 2020 May 14, 2020	SELL	$23.65 - $40.96 $87,623 - $151,756	-3,705 Reduced 36.62%	6,412 $224,000
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $137,085 - $264,559	10,117 New	10,117 $247,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.